CN120603816A - 2-氮杂双环[3.1.1]庚烷化合物 - Google Patents
2-氮杂双环[3.1.1]庚烷化合物Info
- Publication number
- CN120603816A CN120603816A CN202380092851.0A CN202380092851A CN120603816A CN 120603816 A CN120603816 A CN 120603816A CN 202380092851 A CN202380092851 A CN 202380092851A CN 120603816 A CN120603816 A CN 120603816A
- Authority
- CN
- China
- Prior art keywords
- azabicyclo
- methyl
- group
- biphenyl
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/22—Bridged ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022-201488 | 2022-12-16 | ||
| JP2022201488 | 2022-12-16 | ||
| PCT/JP2023/044987 WO2024128305A1 (ja) | 2022-12-16 | 2023-12-15 | 2-アザビシクロ[3.1.1]ヘプタン化合物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN120603816A true CN120603816A (zh) | 2025-09-05 |
Family
ID=91485946
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202380092851.0A Pending CN120603816A (zh) | 2022-12-16 | 2023-12-15 | 2-氮杂双环[3.1.1]庚烷化合物 |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP4635944A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JPWO2024128305A1 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20250112793A (cg-RX-API-DMAC7.html) |
| CN (1) | CN120603816A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2023395547A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2025006722A (cg-RX-API-DMAC7.html) |
| TW (1) | TW202430169A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2024128305A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20260012686A (ko) * | 2024-07-18 | 2026-01-27 | (주)셀트리온 | 신규한 오렉신 2 수용체 작용제 및 이의 용도 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015056100A2 (en) | 2013-10-14 | 2015-04-23 | Marvell World Trade Ltd. | Systems and methods for graphics process units power management |
| SG11201604639YA (en) | 2013-12-12 | 2016-07-28 | Univ Tsukuba | Sulfonamide derivative or pharmaceutically acceptable acid addition salt thereof |
| JP6359924B2 (ja) | 2014-09-17 | 2018-07-18 | トヨタ自動車株式会社 | 非接触送受電システム |
| SG11201806429PA (en) | 2016-02-04 | 2018-08-30 | Takeda Pharmaceuticals Co | Substituted piperidine compound and use thereof |
| US10428023B2 (en) * | 2017-08-03 | 2019-10-01 | Takeda Pharmaceutical Company Limited | Heterocyclic compound and use thereof |
| CA3074059A1 (en) * | 2017-09-01 | 2019-03-07 | Chronos Therapeutics Limited | Substituted 2-azabicyclo[3.1.1]heptane and 2-azabicyclo[3.2.1]octane derivatives as orexin receptor antagonists |
| WO2019081939A1 (en) * | 2017-10-25 | 2019-05-02 | Chronos Therapeutics Limited | 2-AZABICYCLO [3.1.1] DERIVATIVES AS ANTAGONISTS OF OREXIN-1 AND OREXIN-2 RECEPTORS |
| PE20211700A1 (es) * | 2019-01-31 | 2021-09-01 | Takeda Pharmaceuticals Co | Compuesto heterociclico y su uso |
| WO2020167701A1 (en) | 2019-02-13 | 2020-08-20 | Merck Sharp & Dohme Corp. | Pyrrolidine orexin receptor agonists |
| KR20260083444A (ko) | 2019-11-25 | 2026-06-05 | 알케르메스,인코포레이티드 | 치환된 마크로사이클릭 화합물 및 관련 치료 방법 |
| PE20221730A1 (es) | 2019-11-27 | 2022-11-07 | Sumitomo Pharma Co Ltd | Derivado de cicloalquilurea |
| CN119235864A (zh) | 2020-07-17 | 2025-01-03 | 卫材R&D管理有限公司 | 取代的哌啶化合物及其用途 |
| US12503475B2 (en) | 2020-09-03 | 2025-12-23 | Centessa Pharmaceuticals (Uk) Limited | Bicyclic-heterocycle derivatives and their uses as orexin-2 receptor agonists |
| CN116969888A (zh) * | 2022-04-24 | 2023-10-31 | 优领医药科技(上海)有限公司 | 含环丙基并环类衍生物、其药学上可接受的盐及其制备方法和应用 |
-
2023
- 2023-12-15 JP JP2024564440A patent/JPWO2024128305A1/ja active Pending
- 2023-12-15 KR KR1020257019334A patent/KR20250112793A/ko active Pending
- 2023-12-15 AU AU2023395547A patent/AU2023395547A1/en active Pending
- 2023-12-15 CN CN202380092851.0A patent/CN120603816A/zh active Pending
- 2023-12-15 TW TW112149084A patent/TW202430169A/zh unknown
- 2023-12-15 EP EP23903586.8A patent/EP4635944A1/en active Pending
- 2023-12-15 WO PCT/JP2023/044987 patent/WO2024128305A1/ja not_active Ceased
-
2025
- 2025-06-09 MX MX2025006722A patent/MX2025006722A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JPWO2024128305A1 (cg-RX-API-DMAC7.html) | 2024-06-20 |
| EP4635944A1 (en) | 2025-10-22 |
| WO2024128305A1 (ja) | 2024-06-20 |
| AU2023395547A1 (en) | 2025-06-26 |
| KR20250112793A (ko) | 2025-07-24 |
| TW202430169A (zh) | 2024-08-01 |
| MX2025006722A (es) | 2025-07-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7840517B2 (ja) | 二環式複素環誘導体およびオレキシン-2受容体アゴニストとしてのそれらの使用 | |
| TWI629263B (zh) | 新穎吡啶衍生物 | |
| CN108026056B (zh) | 作为组蛋白脱乙酰酶6抑制剂的1,3,4-噁二唑酰胺衍生物化合物及其药物组合物 | |
| CA2770475C (en) | Novel pyrrolidine derived beta 3 adrenergic receptor agonists | |
| AU2014369180B2 (en) | Heteroaryl butanoic acid derivatives as LTA4H inhibitors | |
| KR101989203B1 (ko) | 피라졸 화합물 및 그의 의약 용도 | |
| US9718840B2 (en) | Condensed 5-oxazolidinone derivative | |
| USRE49686E1 (en) | Nitrogen-containing heterocyclic compound and use of same | |
| TW200838515A (en) | Fused ring compound | |
| CN107001259B (zh) | 作为taar配体的取代的氮杂环丁烷衍生物 | |
| AU2014369180A1 (en) | Heteroaryl butanoic acid derivatives as LTA4H inhibitors | |
| JP2024520395A (ja) | 置換される縮合二環式大環状化合物および関連のある治療方法 | |
| TWI911592B (zh) | 用於治療或預防冠狀病毒感染之蛋白酶抑制劑 | |
| TW202325274A (zh) | 抗菌化合物 | |
| KR20250112793A (ko) | 2-아자비시클로[3.1.1]헵탄 화합물 | |
| CN101300226B (zh) | 对组蛋白脱乙酰酶具有抑制活性的烷基氨甲酰基萘氧基辛烯酰基羟基酰胺衍生物及其制备方法 | |
| MX2010014146A (es) | Inhibidores de renina y metodo de uso de los mismos. | |
| KR101950057B1 (ko) | 파록세틴 유도체 | |
| CN103492366B (zh) | 伯胺二醇二氮烯鎓杂环衍生物 | |
| TWI670262B (zh) | 新穎雜芳基丁酸衍生物 | |
| HK1258700A1 (zh) | 锥虫抑制剂 | |
| HK40070249A (en) | Benzyl amine-containing 5,6-heteroaromatic compounds useful against mycobacterial infection | |
| HK40120402A (en) | Dihydrooxadiazinone compound and pharmaceutical use thereof | |
| CN101208010A (zh) | 用于治疗月经前病症的β-内酰氨基链烷酸 | |
| TW200808724A (en) | Piperidine derivative and use thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |